case_images: PMC8651386_01
case_images: ITP diagnosis and treatment timeline. Major dates in the patient's initial ITP presentation and treatment course occurring in 2019 are listed along the x-axis with accompanying hash marks and events above. Daily platelet counts (/microL) and LDH (U/L) where available are listed below respective dates. The above timeline includes major therapies with which the patient was treated, spanning across dates received including prednisone 1 mg/kg (blue bar), IVIG (red bar), dexamethasone 40 mg (yellow bar), and romiplostim 120 mcg (green bar). Overlapping bars imply multiple treatments given on same days.
case_images: CRIM2021-6869342.001.jpg
case_images: PMC8651386_01_CRIM2021-6869342.001.jpg
case_images: fig1
case_images: Despite steroids and 2 additional platelet transfusions over the next two days, his platelets remained 4,000/microL, prompting transfer to our facility for IVIG consideration (Figure 1).
case_images: TTP diagnosis and treatment timeline. Major dates in patient's TTP presentation and treatment course occurring in 2020 are listed along the x-axis with accompanying hash marks and events above. The red scale break on the x-axis signifies large relative gap in time between dates. Daily platelet counts (/microL) and LDH (U/L) where available are listed below respective dates. The above timeline includes major therapies with which the patient was treated, spanning across dates received including dexamethasone 40 mg (red bar), prednisone 1 mg/kg (blue bar), and plasma exchange (TPE, green bar). Overlapping bars imply multiple treatments given on same days.
case_images: CRIM2021-6869342.002.jpg
case_images: PMC8651386_01_CRIM2021-6869342.002.jpg
case_images: fig2
case_images: Given the high likelihood for TTP, he received urgent plasmapheresis (Figure 2).